Estimation of quality of life in Cypriot patients with inflammatory bowel disease

Table 1 Demographic and disease characteristics of the study population n (%)

	Total	CD	UC	P value
	n = 100	n = 40	n = 60
Sex				0.198
Male	54 (53.5)	61.5%	48.3%
Female	46 (46.5)	38.5%	51.7%
Age (yr) (n = 97)		n = 38	n = 59
18-35	39 (39.8)	16 (41.0)	23 (39.0)	0.979
35-50	28 (28.6)	11 (28.2)	17 (28.8)
> 51	30 (31.6)	11 (30.8)	19 (32.2)
Smoking	32 (33.0)	43.2%	26.7%	0.092
Education				0.673
Primary or less	17.3%	18.4%	16.7%
Secondary	49.0%	42.1%	53.3%
Tertiary or above	33.7%	39.5%	30.0%
Employment status				0.349
Government officials	19.8%	22.9%	18.3%
Private employee	44.8%	44.4%	45.0%
Self–employed	4.2%	8.3%	1.7%
Unemployed	31.3%	25.0%	35.0%
Family status				0.822
Married	62.6%	59.0%	65.0%
Unmarried	32.3%	35.9%	30.0%
Divorced	5.1%	5.1%	5.0%
Surgery	20.9%	36.1%	11.7%	0.004
Mean disease duration (yr)	12.63%	10.28%	14.07%	0.118
Treatment				0.019
Immunosuppressive treatment	65.0%	55.0%	71.7%
Immunosuppressive treatment + corticosteroids	16.0%	12.5%	18.3%
Treatment with biologic agents	19.0%	32.5%	10.0%
Treatment with corticosteroids	22.0%	17.5%	25.0%	0.375%

CD: Crohn’s disease; UC: Ulcerative colitis.